financetom
Business
financetom
/
Business
/
XPeng projects lower-than-expected quarterly revenue on stiff competition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
XPeng projects lower-than-expected quarterly revenue on stiff competition
Aug 20, 2024 4:40 AM

Aug 20 (Reuters) - Chinese firm XPeng ( XPEV )

forecast third-quarter revenue below analysts' expectations and

missed June-quarter sales estimates on Tuesday, hurt by stiff

competition and a drop in demand for its aging line-up of pricey

electric vehicles.

The company, however, expects to deliver between 41,000 and

45,000 vehicles in the third quarter, slightly above 40,008

units a year earlier.

U.S.-listed shares of the Guangzhou, China-based company

rose about 2% in premarket trading as it reported an improvement

in gross margin of 1.1 percentage points to 14% in the second

quarter after technical improvements and revenue from its

collaboration with Volkswagen Group.

The company is planning to refresh its model lineup by

launching a range of new EVs in the next three years, priced

between 100,000 yuan and 400,000 yuan ($14,001.88 and

$56,007.51), to grab market share from domestic players such as

BYD, Nio and U.S. automaker Tesla

.

It plans to launch the MONA M03 mid-sized sedan this month,

which is set to compete with BYD's Seagull, Dolphin and the

higher-priced Tesla Model 3.

XPeng ( XPEV ) has seen its expansion plans temporarily throttled by

the European Commission's move to impose tariffs on electric

vehicles made in China to prevent a flood of cars built with

state subsidies.

It is among the Chinese companies considering setting up a

manufacturing plant in the region to avoid those tariffs.

Vehicle margin in the April-June period improved to 6.4%

from 5.5% in the prior quarter. It expects deliveries in the

third quarter to be between 41,000 and 45,000 vehicles, compared

with 40,008 units in the corresponding quarter of last year.

XPeng's ( XPEV ) revenue rose to 8.11 billion yuan ($1.14 billion),

while analysts had expected revenue of 8.17 billion yuan,

according to LSEG data.

It expects third-quarter revenue between 9.1 billion yuan

and 9.8 billion yuan, compared with analysts' estimates of 10.4

billion yuan.

($1 = 7.1419 Chinese yuan renminbi)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen Says Leqembi Approved in Australia as Treatment for Alzheimer's Disease; Shares Up Pre-Bell
Biogen Says Leqembi Approved in Australia as Treatment for Alzheimer's Disease; Shares Up Pre-Bell
Sep 24, 2025
08:11 AM EDT, 09/24/2025 (MT Newswires) -- Biogen (BIIB) and Eisai said Wednesday that Australia's Therapeutic Goods Administration approved Leqembi for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease. The approval follows a review process after the regulatory agency initially did not approve the drug in February, the company said. Leqembi targets toxic protofibrils and...
Two US senators urge Tinder parent to act against dating scams on its apps
Two US senators urge Tinder parent to act against dating scams on its apps
Sep 24, 2025
(Reuters) -Two U.S. senators sent a letter to Tinder parent Match on Wednesday, pushing for action against dating scams on the company's platforms and asking for information about its efforts to detect frauds and protect its users. In a letter to Match CEO Spencer Rascoff, Democratic Senator Maggie Hassan and Republican Senator Marsha Blackburn asked the company to provide documents...
Harmony Biosciences' genetic disorder drug fails to meet main goal in late-stage trial
Harmony Biosciences' genetic disorder drug fails to meet main goal in late-stage trial
Sep 24, 2025
Sept 24 (Reuters) - Harmony Biosciences ( HRMY ) said on Wednesday its experimental drug for a type of rare genetic disorder failed to meet the main goal in a late-stage trial. ...
Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter
Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter
Sep 24, 2025
Sept 24 (Reuters) - Miner Freeport-McMoRan said on Wednesday that it was expecting consolidated sales to be about 4% lower for copper and nearly 6% lower for gold in the third quarter, compared with its prior forecast. (Reporting by Pooja Menon in Bengaluru; Editing by Anil D'Silva) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved